Skip to main content
    T

    Tenet Healthcare Corporation (THC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $291.90
    +5.88 (+2.05%)

    Market Cap: $22.76B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tenet Healthcare Corporation (THC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Tenet Healthcare (THC) trades at 13.1x trailing earnings and 1.1x sales. Its P/E of 13.1x is above its 5-year median of 11.3x. Its forward P/E is 15.0x. The median P/E across 12 similar companies is 15.6x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 12.7% lower over the next year. Its free cash flow yield is 14.2%.

    MultipleValue
    P/E (trailing)13.1x
    Forward P/E15.0x
    Price to sales1.1x
    Price to book4.3x
    EV/EBITDA5.2x
    Price to FCF7.0x
    EV/FCF10.2x
    PEG1.9
    FCF yield14.2%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 18.0% above 11.1x and its P/S is 175.0% above 0.4x.

    MultipleCurrent5-year median10-year median
    P/E13.1x11.3x11.1x
    P/S1.1x0.7x0.4x
    P/B4.3x4.5xN/A
    Medians of month-end values through Oct 2026: 57 to 60 months (5-year) and 100 to 114 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 5.1x in 2020 to 19.2x in 2017.

    Year endPriceP/EP/SP/B
    2025$198.7211.8x0.8x4.1x
    2024$126.2310.6x0.6x2.9x
    2023$75.5710.8x0.4x4.9x
    2022$48.797.1x0.3x4.5x
    2021$81.6910.8x18.2x8.7x
    2020$39.935.1x0.2x152.9x
    2019$38.0314.2x0.2xN/A
    2018$17.149.2xN/AN/A
    2017$15.1619.2xN/AN/A
    2016$14.8414.1xN/A3.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About THC

    What is THC's forward P/E ratio?

    Tenet Healthcare has a forward P/E ratio of 15.0x.

    Is THC stock overvalued?

    GNG's valuation label for THC is Overvalued. Its P/E of 13.1x compares with a median of 15.6x across 12 similar companies.

    What is THC's price to sales ratio?

    Tenet Healthcare has a price to sales ratio of 1.1x.

    What is Tenet Healthcare's average P/E ratio over 5 years?

    Tenet Healthcare's median P/E over the last 5 years is 11.3x, from 60 month-end values through Oct 2026.

    What is THC's PEG ratio?

    Tenet Healthcare has a PEG ratio of 1.9.